Prophylaxis and Treatment of Pneumocystis jiroveci Pneumonia in Lymphoma Patients Subjected to Rituximab-Contained Therapy: A Systemic Review and Meta-Analysis-Reference-Cited by-全球学者库

Prophylaxis and Treatment of Pneumocystis jiroveci Pneumonia in Lymphoma Patients Subjected to Rituximab-Contained Therapy: A Systemic Review and Meta-Analysis

Published:2015-04-24 Issue:4 Volume:10 Page:e0122171
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Jiang Xuqin,Mei Xiaodong,Feng Di,Wang Xiaojing

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference81 articles.

1. Low prevalence of Pneumocystis pneumonia (PCP) but high prevalence of pneumocystis dihydropteroate synthase (dhps) gene mutations in HIV-infected persons in Uganda;SM Taylor;PLoS One,2012

2. Pneumocystis pneumonia in patients treated with rituximab;I Martin-Garrido;Chest,2013

3. Pneumocystis jiroveci pneumonia in patients with non-Hodgkin's lymphoma after Rituximab-containing regimen: two cases of report and literature review;XQ Jiang;J Thorac Dis,2013

4. Three cases of Pneumocystis jirovecii pneumonia (PCP) during first-line treatment with rituximab in combination with CHOP-14 for aggressive B-cell non-Hodgkin's lymphoma;AC Venhuizen;Eur J Haematol,2008

5. Non-Hodgkin's lymphoma. Clinical practice guidelines in oncology;AD Zelenetz;J Natl Compr Canc Netw,2006

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk of Severe Infections Secondary to the Use of Targeted Therapies in Hematological Malignancies;Cureus;2024-01-10

2. Clinical Characteristics and Outcomes of Pneumocystis jirovecii Pneumonia in Cancer Patients From a Tertiary Care Hospital;Cureus;2023-12-29

3. New anticancer therapeutics impact fungal pathobiology, infection dynamics, and outcome;PLOS Pathogens;2023-12-21

4. Pneumocystis jirovecii with high probability detected in bronchoalveolar lavage fluid of chemotherapy-related interstitial pneumonia in patients with lymphoma using metagenomic next-generation sequencing technology;Infectious Agents and Cancer;2023-12-06

5. A review of prophylactic regimens to prevent invasive fungal infections in hematology patients undergoing chemotherapy or stem cell transplantation;Expert Review of Hematology;2023-12-02